Clinical Trials Directory

Trials / Sponsors / ITB-Med LLC

ITB-Med LLC

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients
ALS
Phase 12024-04-16
Active Not RecruitingA Study of TCD601 in de Novo Renal Transplant Recipients
Renal Transplantation
Phase 22023-12-28
TerminatedA Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
Diabetes Mellitus, Type 1
Phase 22023-01-23
TerminatedA Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA)
Kidney Transplantation
Phase 22023-01-17
Active Not RecruitingA Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)
Kidney Transplantation
Phase 22022-12-14
Active Not RecruitingA Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
Liver Transplantation
Phase 22022-06-29
TerminatedA Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation
Kidney Transplantation
Phase 22021-06-06
CompletedA Dose Escalation Study in de Novo Renal Transplantation
Kidney Transplantation
Phase 22021-05-26